FUJIFILM Irvine Scientific acquires AI license for IVF

Jun. 22, 2022 11:03 AM ETFUJIFILM Holdings Corporation (FUJIY)By: Manshi Mamtora, CFA

Blastocyst Fertility

wildpixel/iStock via Getty Images

  • FUJIFILM Irvine Scientific (OTCPK:FUJIY) has exclusively licensed the intellectual property relating to artificial intelligence (or AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates.
  • The technology was developed and patented jointly by investigators from Brigham and Women’s Hospital and Massachusetts General Hospital with expertise in artificial intelligence, biomedical engineering and IVF.
  • “Already a leading company of AI and medical imaging, Fujifilm will look for synergies across its healthcare companies to develop innovative applications that leverage this technology. Together we will continue to discover new ways to use imaging and artificial intelligence to improve healthcare.” said Yutaka Yamaguchi, CEO and chairman of FUJIFILM Irvine Scientific, general manager of Fujifilm Life Science Business Division.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.